Sartori, A.; Corno, C.; De Cesare, M.; Scanziani, E.; Minoli, L.; Battistini, L.; Zanardi, F.; Perego, P.
Efficacy of a Selective Binder of αVβ3 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models. Cancers 2019, 11, 531.
https://doi.org/10.3390/cancers11040531
AMA Style
Sartori A, Corno C, De Cesare M, Scanziani E, Minoli L, Battistini L, Zanardi F, Perego P.
Efficacy of a Selective Binder of αVβ3 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models. Cancers. 2019; 11(4):531.
https://doi.org/10.3390/cancers11040531
Chicago/Turabian Style
Sartori, Andrea, Cristina Corno, Michelandrea De Cesare, Eugenio Scanziani, Lucia Minoli, Lucia Battistini, Franca Zanardi, and Paola Perego.
2019. "Efficacy of a Selective Binder of αVβ3 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models" Cancers 11, no. 4: 531.
https://doi.org/10.3390/cancers11040531
APA Style
Sartori, A., Corno, C., De Cesare, M., Scanziani, E., Minoli, L., Battistini, L., Zanardi, F., & Perego, P.
(2019). Efficacy of a Selective Binder of αVβ3 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models. Cancers, 11(4), 531.
https://doi.org/10.3390/cancers11040531